欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > DNADamage/DNARepair > Elafibranor

浏览历史

S87309

Elafibranor

源叶(MedMol) 99%
  • 英文名:
  • Elafibranor
  • 别名:
  • CAS号:
  • 923978-27-2
  • 分子式:
  • C22H24O4S
  • 分子量:
  • 384.4886
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S87309-1mg 99% ¥197.20元 10 - - - EA 加入购物车
源叶(MedMol) S87309-2mg 99% ¥319.60元 10 - - - EA 加入购物车
源叶(MedMol) S87309-5mg 99% ¥408.00元 10 - - - EA 加入购物车
源叶(MedMol) S87309-10mg 99% ¥578.00元 7 - - - EA 加入购物车
源叶(MedMol) S87309-25mg 99% ¥1224.00元 5 - - - EA 加入购物车
源叶(MedMol) S87309-50mg 99% ¥2176.00元 3 - - - EA 加入购物车
源叶(MedMol) S87309-100mg 99% ¥3400.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Elafibranor (GFT505) 是PPAR-alpha和PPAR-δ的激动剂,改善胰岛素敏感度、有益于葡萄糖稳态、脂质代谢并减少炎症
  • 靶点: PPARα; PPARδ ;PPAR
  • 体外研究:
    GFT505 is a novel PPAR modulator that shows a preferential activity on PPAR-α and concomitant activity on PPAR-δ
  • 体内研究:
    Elafibranor (GFT505) is a dual PPARα/δ agonist that has demonstrated efficacy in disease models of nonalcoholic fatty liver disease (NAFLD)/NASH and liver fibrosis. In the rat, GFT505 concentrated in the liver with limited extrahepatic exposure and underwent extensive enterohepatic cycling. Elafibranor confers liver protection by acting on several pathways involved in NASH pathogenesis, reducing steatosis, inflammation, and fibrosis. GFT505 improved liver dysfunction markers, decreased hepatic lipid accumulation, and inhibited proinflammatory (interleukin-1 beta, tumor necrosis factor alpha, and F4/80) and profibrotic (transforming growth factor beta, tissue inhibitor of metalloproteinase 2, collagen type I, alpha 1, and collagen type I, alpha 2) gene expression
  • 细胞实验: Cell lines: hSKP-HPCs Concentrations: 30 µM Incubation Time: 24 h Method: Cells were treated with indicated concentration of drug for 24 h.
  • 动物实验: Animal Models: hApoE2 KI and hApoE2 KI/PPAR-α KO mice Dosages: 30 mg/kg Administration: oral gavage
  • 参考文献:
    1. Ratziu V, et al. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening. Gastroenterology. 2016, 150(5):1147-1159.e5. 2. Staels B, et al. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 2013, 58(6):1941-52. 3. Boeckmans J, et al. Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH. Pharmacol Res. 2019 Jun;144:377-389.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.601 ml 13.004 ml 26.009 ml
    5 mM 0.52 ml 2.601 ml 5.202 ml
    10 mM 0.26 ml 1.3 ml 2.601 ml
    50 mM 0.052 ml 0.26 ml 0.52 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。